text.skipToContent text.skipToNavigation
You searched for "vivo"
Too many choices? Use the filter option on the left to narrow your product listing.
91-100 of 323 results
  • Human Peripheral Blood CD8+ T Cells, Cryopreserved, 10 million cells
    Compare
    Human Peripheral Blood CD8+ T Cells, Cryopreserved, 10 million cells
    Catalog #: 2W-300
    Cryopreserved ampule of Human Peripheral Blood CD8+ T Cells containing 10 million cells
    Sales unit: Ampule
    AMP
  • 4D-Nucleofector<sup class=reg>®</sup> Y Unit
    Compare
    4D-Nucleofector® Y Unit
    Catalog #: AAF-1003Y

    Enables the direct Nucleofection® of cells in adherence in 24-well culture plates

    Sales unit: items
    ST
  • Cryo Human Leukopak (2.5 Billion Cells)
    Compare
    Cryo Human Leukopak (2.5 Billion Cells)
    Catalog #: 260280.01
    Cryopreserved human leukapheresis product collected from normal peripheral blood, containing ≥2.5 billion cells
    Sales unit: Bag
    BG
  • HepaRG™ Thawing and Plating Medium Supplement
    Compare
    HepaRG™ Thawing and Plating Medium Supplement
    Catalog #: MHTAP
    HepaRGTM Thawing and Plating Medium Supplement
    Sales unit: Bottle
    BOT
  • Lucetta<sup class=reg>®</sup> 2  Luminometer
    Compare
    Lucetta® 2 Luminometer
    Catalog #: AAL-1002

    For measuring all sorts of glow luminescence. Provides results for MycoAlert® Mycoplasma Detection Assays immediately.

    Sales unit: items
    ST
  • Gentamicin Sulfate-Amphotericin (GA-1000) , 5 mL
    Compare
    Gentamicin Sulfate-Amphotericin (GA-1000) , 5 mL
    Catalog #: CC-4083
    GA-1000, Gentamicin-Amphotericin, 5 mL
    Sales unit: Vial
    VIA
  • Mouse CD1 Brain Mixed Astrocytes
    Compare
    Mouse CD1 Brain Mixed Astrocytes
    Catalog #: M-ASM-430
    Cryopreserved ampule of Mouse CD1 Mixed Astrocytes containing ≥ 1 million cells
    Sales unit: each
    EA
  • HepaRG™ Induction Medium Supplement
    Compare
    HepaRG™ Induction Medium Supplement
    Catalog #: MHIND
    HepaRGTM Induction Medium Supplement
    Sales unit: Bottle
    BOT
  • FlashGel<sup class=reg>®</sup> FLX Cassettes
    Compare
    FlashGel® FLX Cassettes
    Catalog #: 00317259
    FlashGel® FLX Cassettes, 1.2% 16+1 double tier, 9 pack
     
    Easily screen 32 samples
     
    DNA: 100 bp – 10 kb separation range (separation of fragments >4kb will be improved by running longer at a lower voltage) 
     
    RNA: 0.5 – 9 kb separation range
    Sales unit: each
    EA
  • FlashGel<sup class=reg>®</sup> FLX Cassettes
    Compare
    FlashGel® FLX Cassettes
    Catalog #: 00317258
    FlashGel® FLX Cassettes, 1.2% 12+1 single tier, 9 pack DNA: 100 bp – 10 kb separation range (separation of fragments >4kb will be improved by running longer at a lower voltage) RNA: 0.5 – 9 kb separation range
    Sales unit: each
    EA
1-10 of 210 results
  • References - X-Vivo™
    Overview of relevant references
  • Primary Normal Human Cells and Media
    In Vivo Relevance. In Vitro Results. Updated and revised cell content.
  • X-VIVO Reference Guide 2025
    A curated list of peer-reviewed articles related to X-VIVO RUO media as used for culturing different primary cells and is a resource for potential consumers to find scientific data.
  • Building Better In Vitro Models Using the Quasi Vivo® System
    Overview webinar providing details and application data using the Quasi Vivo® Systems delivered by Dr. Kelly Davidge, Scientist at Kirkstall Inc.
    Watch Video
  • Terms and Conditions TheraPEAK® T-VIVO® Sample Request Program
    Terms and Conditions TheraPEAK® T-VIVO® Sample Requests
  • Instructions for Use – TheraPEAK® X-VIVO® Cell Culture Medium
    Instructions for how to use the X-VIVO® Media Series
  • TheraPEAK® T-VIVO® Cell Culture Medium – Overview
    View or download this document for a comprehensive overview and learn how the chemically defined TheraPEAK® T-VIVO® Medium enhances T-cell culture and accelerates therapy development.
  • TheraPEAK® X-VIVO® Hematopoietic Cell Culture Medium
    Serum-free, GMP produced medium for cell therapy applications
  • Non-viral Gene Modification for Ex-vivo Cell Therapy
    In this interview our Director Transfection R&D discusses the advantages of non-viral transfection technologies for CRISPR- or transposon-based genetic modification cell and gene therapy.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System